Assignee
ALTAREX MEDICAL CORP
CA·4 granted patents·8 pending applications·67 citations·filing 1999–2008
Top patents by PatentIndex Score
12 records- 0185US7147850B2Therapeutic binding agents against MUC-1 antigen and methods for their useALTAREX MEDICAL CORP·Filed 2001·Granted Dec 12, 2006·19 cites·23 claims
- 0281US6881405B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 1999·Granted Apr 19, 2005·45 cites·9 claims
- 0371US2008311127A1Combination therapy for treating diseaseALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 0467US2007036798A1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseALTAREX MEDICAL CORP·Filed 2006·Application pending·0 cites
- 0565US2008131443A1Method and composition for reconforming multi-epitopic antigens to intiate an immune responseALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 0658US2007092522A1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseALTAREX MEDICAL CORP·Filed 2006·Application pending·0 cites
- 0757US7579445B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2004·Granted Aug 25, 2009·0 cites·9 claims
- 0857US2009220493A1Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 0956US2009291075A1Binding agents and their use in targeting tumor cellsALTAREX MEDICAL CORP·Filed 2008·Application pending·0 cites
- 1055US2005260208A1Binding agents and their use in targeting tumor cellsALTAREX MEDICAL CORP·Filed 2003·Application pending·0 cites
- 1155US2009202560A1Method for diagnosing efficacy of xenotypic antibody therapyALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 1234US7318921B2Therapeutic compositions that alter the immune responseALTAREX MEDICAL CORP·Filed 1999·Granted Jan 15, 2008·3 cites·76 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →